1st Optimal Medical Leadership and Credentials: An Independent Review

What Is 1st Optimal and How Does Its Clinical Model Work?

1st Optimal operates as a cash-pay concierge telehealth practice that markets performance and longevity medicine to adults seeking prescription therapies such as testosterone replacement therapy (TRT), hormone replacement therapy (HRT), and compounded peptides. Patients pay out of pocket and are connected with prescribing clinicians through an online platform rather than a brick-and-mortar clinic.

The Concierge Cash-Pay Structure

Concierge telehealth companies that collect direct fees from patients without insurance billing operate under specific regulatory obligations that differ from standard fee-for-service practices. The prescribing clinician must hold an active, unrestricted license in the patient's state of residence. This requirement is not optional. The Interstate Medical Licensure Compact (IMLC), which 40 states have joined as of 2024, allows expedited multi-state licensure but does not eliminate the individual state license requirement. National telehealth policy on prescribing across state lines is governed by state-specific medical practice acts and reviewed by the Federation of State Medical Boards.

Cash-pay models also remove the utilization-management guardrails that commercial payers impose. That increases patient access to certain therapies, but it also means the entire burden of clinical appropriateness falls on the prescribing physician and the patient's own due diligence.

What Therapies 1st Optimal Promotes

The company's marketing centers on:

• Testosterone cypionate or enanthate for male hypogonadism
• Estradiol, progesterone, and DHEA-based protocols for female hormone optimization
• Compounded peptides such as BPC-157, CJC-1295, ipamorelin, and PT-141
• Thyroid optimization protocols

Each category carries distinct regulatory and safety considerations addressed in the sections below.

How to Verify a 1st Optimal Prescriber's Credentials

Patients cannot safely assess any telehealth practice without checking the actual licenses of the humans signing their prescriptions. The process takes under ten minutes and is free.

Step 1: Obtain the Prescriber's Full Name, NPI, and State of Licensure

Ask 1st Optimal (or any telehealth platform) for the full legal name, National Provider Identifier (NPI) number, and state of licensure of every clinician who will prescribe for you. Any legitimate practice will provide these without hesitation. The NPI number can be confirmed at the CMS NPI Registry, a public federal database.

Step 2: Cross-Check the State Medical Board License

Every state medical board maintains a free, publicly searchable license verification portal. Enter the physician's name or license number to confirm:

1. Active license status (not expired, suspended, or revoked)
2. No disciplinary actions, consent orders, or probationary conditions
3. Specialty training consistent with the therapies being prescribed

The Federation of State Medical Boards' DocInfo tool aggregates board actions across participating states. A single prior consent order for inappropriate prescribing is a meaningful finding, not a bureaucratic footnote.

Step 3: Check for Board Certifications

Board certification is voluntary but meaningful. A clinician prescribing testosterone, thyroid medications, and estradiol ideally holds certification from the American Board of Internal Medicine (ABIM), the American Board of Family Medicine (ABFM), or the American Board of Obstetrics and Gynecology (ABOG). Certification can be verified through the American Board of Medical Specialties (ABMS) physician verification tool.

Nurse practitioners (NPs) and physician assistants (PAs) frequently prescribe in telehealth practices. Their credentials are verified through separate boards: the American Nurses Credentialing Center (ANCC) for NPs and the National Commission on Certification of Physician Assistants (NCCPA) for PAs. Neither is inferior to MD/DO prescribing by default, but scope-of-practice laws vary by state, and some states require physician supervision for mid-level prescribers.

Is 1st Optimal Legit? What the Verification Checkpoints Show

"Legit" in the context of a telehealth pharmacy practice means at least four things: licensed prescribers, a licensed and accredited dispensing pharmacy, compliance with FDA drug regulations, and transparent business practices. Each deserves its own assessment.

Prescriber Licensure: The Non-Negotiable Floor

A company can have polished branding and enthusiastic patient testimonials and still have prescribers whose licenses carry disciplinary history. License verification, as described above, is the only way to know. HealthRX recommends running every prescriber's name through their state board database before submitting payment. This applies to 1st Optimal and every other concierge telehealth company.

Compounding Pharmacy Accreditation

1st Optimal, like most peptide and TRT telehealth companies, likely dispenses medications through a compounding pharmacy rather than a traditional retail chain. Compounding pharmacies exist in two federal categories under the Drug Quality and Security Act of 2013 (DQSA): 503A traditional compounders and 503B outsourcing facilities. The FDA maintains a public list of registered 503B outsourcing facilities that have agreed to comply with Current Good Manufacturing Practice (CGMP) standards.

The Pharmacy Compounding Accreditation Board (PCAB), a division of URAC, grants voluntary accreditation to compounders that meet quality and safety standards. Patients should ask 1st Optimal which compounding pharmacy fills their prescriptions and then verify that pharmacy's accreditation status at PCAB's accreditation search.

A non-accredited, non-503B-registered compounder is a material safety concern, particularly for injectable preparations such as testosterone, peptides, and HCG.

LegitScript Certification

LegitScript is an independent pharmacy verification service that the FDA and major payment processors rely on to identify illegitimate online pharmacies. A LegitScript-certified pharmacy has undergone background checks on ownership, licensure, and prescription verification practices. LegitScript's online pharmacy database allows free public searches. If the pharmacy fulfilling 1st Optimal prescriptions does not appear in LegitScript's certified database, that is a yellow flag that warrants direct inquiry.

BBB Profile and Complaint History

The Better Business Bureau (BBB) is not a government regulator, but its complaint database provides a useful signal about billing disputes, failure to deliver medications, and unresponsive customer service. As of the date of this review, patients should check 1st Optimal's BBB profile directly by searching the company name and state of incorporation. Pay attention to:

• The ratio of resolved to unresolved complaints
• Whether complaints cluster around specific issues (billing, prescription delays, medication quality)
• How recently the most recent complaint was filed

A company with fewer than five complaints over three years and a pattern of resolution is materially different from one with 30+ unresolved billing disputes.

The HealthRX 5-Point Telehealth Legitimacy Framework applies here. Before paying any cash-pay telehealth company for a controlled substance or compounded injectable, confirm: (1) active state license for every prescriber, (2) 503B registration or PCAB accreditation for the dispensing pharmacy, (3) LegitScript certification for the online pharmacy portal, (4) a clear BBB complaint ratio below one unresolved complaint per 12 months of operation, and (5) a written treatment agreement that names the prescribing physician and includes a process for urgent clinical questions. Companies that cannot satisfy all five are operating with incomplete patient-safety infrastructure.

FDA Compliance for Compounded Peptides: A Critical Gap Area

Compounded peptides are the single largest regulatory gray area in the performance-medicine telehealth space. BPC-157, ipamorelin, CJC-1295, and most other peptides currently marketed by longevity clinics are not FDA-approved drugs. They are synthesized as research chemicals or compounded preparations.

The FDA's Position on "Essentially a Copy" and Bulk Drug Substances

Under 21 U.S.C. 503A, a compounding pharmacy may prepare a drug for an individual patient that is not commercially available, but it may not compound a drug that is "essentially a copy" of an FDA-approved product. Peptides that have no approved equivalent occupy a murkier category. The FDA has published guidance stating that bulk drug substances used in compounding must appear on an FDA-approved list, and most peptides currently sold by telehealth companies do not appear on that list. The FDA's list of bulk drug substances under evaluation for 503A use is publicly available.

In 2024, the FDA sent warning letters to compounders producing semaglutide and tirzepatide copies during the shortage period, a pattern that previews potential enforcement action in the peptide space as well.

What Patients Ordering Peptides Should Know

Patients prescribed BPC-157 or similar compounds through 1st Optimal should ask the following before paying:

• Is this compound on the FDA 503A bulk drug substance list?
• Is the compounding pharmacy registered as a 503B outsourcing facility?
• What certificates of analysis (COAs) are available for the specific batch?
• What is the sterility testing protocol for injectable preparations?

A prescribing clinician who cannot answer these questions, or who dismisses them as overly technical, is not providing adequate informed consent.

TRT and HRT Prescribing Standards: What Legitimate Care Looks Like

Testosterone and hormone prescribing through telehealth is legal and often clinically appropriate. The question is whether the prescribing pattern at any given company follows published clinical guidelines.

Testosterone Replacement Therapy

The American Urological Association (AUA) 2018 guidelines and the Endocrine Society's 2018 clinical practice guideline for testosterone therapy both require a confirmed diagnosis of hypogonadism based on at least two morning serum testosterone measurements below the laboratory's lower reference limit (typically below 300 ng/dL), plus the presence of signs and symptoms. The Endocrine Society guideline is available here.

A telehealth company that prescribes testosterone based on a single questionnaire and a finger-prick test without confirmed morning serum levels is operating outside these guidelines. Patients should ask 1st Optimal whether their laboratory protocol requires two morning total testosterone draws before initiating therapy.

Female Hormone Optimization

The Menopause Society (formerly NAMS) 2023 position statement affirms that hormone therapy is appropriate for menopausal symptom management in women under 60 or within 10 years of menopause onset, absent contraindications such as active breast cancer or prior venous thromboembolism. The full position statement is available at menopause.org.

Female patients using 1st Optimal for HRT should confirm that their prescriber reviewed a full pelvic and breast history before initiating estrogen, and that progesterone is co-prescribed for any patient with an intact uterus.

What to Do If You Have a Complaint or Adverse Event

Patient complaints about a telehealth company can and should be directed to multiple channels simultaneously.

State Medical Board

If a prescriber behaved inappropriately, prescribed without adequate evaluation, or ignored adverse event reports, the state medical board in the prescriber's licensing state has jurisdiction. Board complaints are free to file. The FSMB directory of state medical boards lists contact information for all 70 member boards.

FDA MedWatch

Adverse events from compounded drugs, including infections from contaminated injectable preparations, are reportable through the FDA MedWatch Safety Reporting Portal. MedWatch reports feed the FDA's signal-detection system and have historically preceded enforcement actions against non-compliant compounders.

Consumer Financial Protection Bureau (CFPB) and State Attorney General

Billing disputes and deceptive marketing claims fall under state consumer-protection statutes and, where electronic payments are involved, CFPB oversight. Document every charge, every communication, and every marketing claim before escalating.

How 1st Optimal Compares to Published Telehealth Safety Standards

The American Telemedicine Association (ATA) and the Federation of State Medical Boards have both published model policies for telehealth prescribing. Key standards include:

• A synchronous video or in-person encounter before prescribing controlled substances or hormones for the first time (the Ryan Haight Online Pharmacy Consumer Protection Act requires this for Schedule III controlled substances, which includes testosterone)
• A documented medical history and physical assessment
• A follow-up protocol, including laboratory monitoring at defined intervals
• A mechanism for urgent clinical questions outside of business hours

The Ryan Haight Act, codified at 21 U.S.C. 829(e), requires that a practitioner conduct at least one in-person medical evaluation before prescribing a Schedule III controlled substance via the internet, unless a DEA-registered telemedicine exception applies. Testosterone is a Schedule III substance. Prospective patients should ask 1st Optimal explicitly how they satisfy this requirement.

The DEA's 2023 proposed rules on telemedicine prescribing of controlled substances, released in response to COVID-era flexibilities expiring, would require in-person evaluations or referral to a DEA-registered telemedicine platform for Schedule III prescribing. The DEA's telemedicine prescribing rulemaking page provides updates as final rules are issued.

Questions to Ask 1st Optimal Before Enrolling

Asking direct questions before paying is the most effective consumer protection tool available. The answers, and the speed with which they arrive, are informative in themselves.

Questions worth asking:

1. What is the full name, NPI, and state license number of my prescribing clinician?
2. Which compounding pharmacy will fill my prescriptions, and is it PCAB-accredited or a 503B-registered outsourcing facility?
3. How do you satisfy the Ryan Haight Act requirement for testosterone prescribing?
4. What laboratory testing is required before initiating TRT or HRT?
5. What is your process if I experience an adverse reaction to a compounded injectable?
6. Are the peptides you prescribe on the FDA's 503A bulk drug substance approved list?
7. Can I see a certificate of analysis for my compounded medication batch?

A company that answers these questions concisely, with documentation, is operating transparently. Deflection, delays, or dismissiveness are meaningful data points.